Form 4: OptimizeRx Executive Theresa Greco Disposes of Shares to Cover Tax Obligations

Theresa Greco, Chief Commercial Officer of OptimizeRx Corp, disposed of 1,693 shares of common stock on November 1, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On November 1, 2024, Theresa Greco, the Chief Commercial Officer of OptimizeRx Corp, disposed of 1,693 shares of common stock.
• The shares were disposed of at a price of $5.15 per share.
• This transaction was to cover tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Greco directly owns 35,345 shares of OptimizeRx Corp.
• The filing of this statement should not be construed as an admission that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or that this Statement is legally required to be filed by such person.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small number of shares being sold by an executive to cover tax obligations.

Key Dates